Envista (NVST) Competitors $20.37 +0.11 (+0.54%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends NVST vs. SOLV, SNN, PEN, GKOS, BLCO, INSP, PRCT, AXNX, NARI, and LIVNShould you be buying Envista stock or one of its competitors? The main competitors of Envista include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Inari Medical (NARI), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. Envista vs. Solventum Smith & Nephew Penumbra Glaukos Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics Axonics Inari Medical LivaNova Solventum (NYSE:SOLV) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, community ranking, earnings, valuation and risk. Do analysts rate SOLV or NVST? Solventum currently has a consensus price target of $68.00, suggesting a potential downside of 0.57%. Envista has a consensus price target of $20.71, suggesting a potential upside of 1.66%. Given Envista's stronger consensus rating and higher possible upside, analysts plainly believe Envista is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Envista 1 Sell rating(s) 11 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.13 Is SOLV or NVST more profitable? Solventum has a net margin of 0.00% compared to Envista's net margin of -53.42%. Envista's return on equity of 3.76% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A Envista -53.42%3.76%2.24% Does the media prefer SOLV or NVST? In the previous week, Solventum had 6 more articles in the media than Envista. MarketBeat recorded 13 mentions for Solventum and 7 mentions for Envista. Envista's average media sentiment score of 0.89 beat Solventum's score of 0.88 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 7 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Envista 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, SOLV or NVST? Solventum has higher earnings, but lower revenue than Envista. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventumN/AN/AN/AN/AN/AEnvista$2.57B1.37-$100.20M-$7.77-2.62 Does the MarketBeat Community favor SOLV or NVST? Envista received 33 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 38.20% of users gave Envista an outperform vote while only 5.88% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes15.88%Underperform Votes1694.12% EnvistaOutperform Votes3438.20% Underperform Votes5561.80% SummaryEnvista beats Solventum on 9 of the 11 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get Envista News Delivered to You Automatically Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVST vs. The Competition Export to ExcelMetricEnvistaDental equipment & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$3.51B$3.47B$5.03B$19.87BDividend YieldN/A1.85%5.16%3.52%P/E Ratio-2.6237.26135.4142.95Price / Sales1.371.951,160.9719.16Price / Cash8.085.3533.5317.86Price / Book0.842.084.675.52Net Income-$100.20M-$33.08M$119.07M$986.45M7 Day Performance1.44%3.95%-1.83%0.45%1 Month Performance9.69%-7.46%-3.60%1.05%1 Year Performance-14.95%134.51%31.66%24.67% Envista Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVSTEnvista3.6426 of 5 stars$20.37+0.5%$20.71+1.7%-14.3%$3.49B$2.57B-2.6212,800SOLVSolventum1.804 of 5 stars$68.39+2.0%$68.00-0.6%N/A$11.58BN/A0.0022,000SNNSmith & Nephew2.1198 of 5 stars$25.22-1.2%N/A-1.4%$11.15B$5.55B0.0018,452PENPenumbra4.3167 of 5 stars$239.20+0.9%$227.92-4.7%+1.6%$9.18B$1.16B278.144,200Analyst ForecastInsider TradeGKOSGlaukos3.8428 of 5 stars$141.44-1.9%$134.55-4.9%+121.3%$7.80B$360.35M-46.83780Positive NewsBLCOBausch + Lomb2.7887 of 5 stars$19.39-0.8%$20.91+7.8%+23.2%$6.88B$4.15B0.0013,300INSPInspire Medical Systems4.9104 of 5 stars$184.88+5.0%$233.58+26.3%+29.2%$5.28B$624.80M172.781,011Analyst UpgradePositive NewsGap UpPRCTPROCEPT BioRobotics1.5867 of 5 stars$92.70-0.9%$89.50-3.5%+180.7%$4.88B$136.19M0.00626AXNXAxonics3.2587 of 5 stars$70.98flat$71.00+0.0%N/A$3.63B$366.38M-591.45610News CoverageNARIInari Medical3.2625 of 5 stars$49.00-3.9%$58.89+20.2%-15.9%$2.98B$493.63M0.001,300Insider TradePositive NewsLIVNLivaNova4.1794 of 5 stars$50.05-2.6%$69.17+38.2%+6.8%$2.79B$1.15B119.172,900 Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Glaukos Alternatives Bausch + Lomb Alternatives Inspire Medical Systems Alternatives PROCEPT BioRobotics Alternatives Axonics Alternatives Inari Medical Alternatives LivaNova Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NVST) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envista Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envista With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.